These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 15043715

  • 1. S100A5: a marker of recurrence in WHO grade I meningiomas.
    Hancq S, Salmon I, Brotchi J, De Witte O, Gabius HJ, Heizmann CW, Kiss R, Decaestecker C.
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):178-87. PubMed ID: 15043715
    [Abstract] [Full Text] [Related]

  • 2. Detection of S100B, S100A6 and galectin-3 ligands in meningiomas as markers of aggressiveness.
    Hancq S, Salmon I, Brotchi J, Gabius HJ, Heizmann CW, Kiss R, Decaestecker C.
    Int J Oncol; 2004 Nov; 25(5):1233-40. PubMed ID: 15492810
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Primary resected meningiomas: relapses and proliferation markers.
    Kalala JP, Caemaert J, De Ridder L.
    In Vivo; 2004 Nov; 18(4):411-6. PubMed ID: 15369177
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recurrence and regrowth of benign meningiomas.
    Nakasu S, Fukami T, Jito J, Nozaki K.
    Brain Tumor Pathol; 2009 Nov; 26(2):69-72. PubMed ID: 19856217
    [Abstract] [Full Text] [Related]

  • 11. [Proliferative markers of meningiomas: immunohistochemical analysis and prognostic value].
    Korshunov AG, Shishkina LV, Golanov AV.
    Arkh Patol; 2002 Nov; 64(1):29-33. PubMed ID: 11889696
    [Abstract] [Full Text] [Related]

  • 12. Expression of apoptotic and proliferation markers in meningiomas.
    Konstantinidou AE, Pavlopoulos PM, Patsouris E, Kaklamanis L, Davaris P.
    J Pathol; 1998 Nov; 186(3):325-30. PubMed ID: 10211124
    [Abstract] [Full Text] [Related]

  • 13. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL, Ke RH, Li B, Wang XH, Wang YN, Wang XQ.
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
    Pistolesi S, Boldrini L, Gisfredi S, De Ieso K, Camacci T, Caniglia M, Lupi G, Leocata P, Basolo F, Pingitore R, Parenti G, Fontanini G.
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Can recurrence of meningiomas be predicted?
    Kalala JP, Benoit D, De Ridder L.
    Anticancer Res; 2004 Apr; 24(4):2319-24. PubMed ID: 15330178
    [Abstract] [Full Text] [Related]

  • 19. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
    Roser F, Nakamura M, Ritz R, Bellinzona M, Dietz K, Samii M, Tatagiba MS.
    Cancer; 2005 Aug 01; 104(3):598-601. PubMed ID: 15952201
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R, Farhoud A, Sure U, Heinze S, Henzel M, Mennel HD, Bertalanffy H.
    Strahlenther Onkol; 2006 Nov 01; 182(11):641-6. PubMed ID: 17072521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.